HALEY DIATTO: Open Payments
NPI 1760814719 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 12 payments from 8 companies in 2025. Trend: 2023 $115 · 2024 $292 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $150 |
| Eisai Inc. | 1 | $125 |
| Corcept Therapeutics | 3 | $64 |
| Novo Nordisk Inc | 2 | $32 |
| Abbott Laboratories | 2 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: DEXCOM G7 GSS (161), Leqembi, Korlym, FREESTYLE LIBRE, TRELEGY ELLIPTA, Ozempic, KEVEYIS, Veozah.
Industry payments across TX — which companies pay providers there.
